RobotStonks scans filings, patents, technical papers, and earnings calls to surface real signals—so you can see which robotics companies are delivering, which tech is commercial, and where smart money is moving.
Robotics tickers under active watch
New material signals last 30 days
Net inflows to industrial leaders
Actual growth vs. media sentiment
Filings • Patents • Calls
Industrial leader shifts spend to autonomous mobile robots
Multi-modal grasp detection hits commercialization thresholds
Rail automation rollouts expanding to 14 sites in Q3
Investors face an onslaught of headlines, hype, and complex jargon. Bad signals lead to bad bets.
We turn dense technical and regulatory data into plain-English insights and actionable signals, starting with industrial robotics.
See which companies ship, deploy, and win contracts—minus PR fluff.
Spot red flags in filings and calls before they hit price action.
Get early signals on tech crossing commercialization thresholds.
Personalized alerts for filings, patents, and deal flow shifts.
3 new contracts >$5M; capex guidance increased 17% QoQ; rollout to 14 sites.
Patent disputes likely to slow perception module updates 1–2 quarters.
Hedge fund disclosures show net additions to top three industrial robotics suppliers.
We parse filings, patents, technical papers, earnings calls, and disclosures across multiple jurisdictions.
AI models map signals to commercial readiness, unit economics, and regulatory impact.
Get plain-English takeaways, watchlists, and alerts so you can position with conviction.
Depth over breadth. We start with industrial robotics and expand to medical, consumer, and defense.
Detect material guidance changes, capex pivots, and risk language shifts before consensus.
Track commercialization thresholds for perception, grasping, locomotion, and control stacks.
Monitor real-world deployments, contract volume, and site expansions—by vertical.
See institutional flows and insider moves tied to concrete technology milestones.
Get notified when filings, patents, or call transcripts cross your thresholds.
Score headlines and social chatter against grounded datasets to de-risk narrative traps.
Start with a 14-day free trial. Cancel anytime.
Find out how well you can spot hype from real opportunity, then get our e‑book on the 7 signals of robotics commercialization.
No. We provide investment intelligence and signals to inform your decisions. We don’t provide personalized financial advice.
Most users recoup the subscription by avoiding one bad trade. Clarity on commercialization and risk saves real money.
We start with industrial robotics and expand to medical, consumer, and defense. Coverage grows weekly.
Regulatory filings, patent offices, technical papers, earnings calls, and fund disclosures—mapped and scored by AI.
Yes. Our Team plan includes seats, API access, and onboarding. We also offer premium reports and consultations.
14‑day free trial, cancel anytime. Annual plans have a 30‑day money-back guarantee.
Robotics will define the next decade. Separate real signals from noise and position with conviction.
Investors who use RobotStonks stay ahead.
From retail investors to research teams, clarity compounds.
Industrial automation basket outperformed relevant index by +11.8% over 6 months with lower drawdown, driven by deployment and filings signals.
“We replaced hours of transcript parsing with RobotStonks. The commercialization signals are spot on—and the alerts have saved us from a few value traps already.”
“I finally understand which robotics stocks are real. The plain-English writeups make complex topics easy, and my watchlist actually performs.”
“The hype filter is underrated. It quantifies narrative risk so we size positions with confidence.”